Evidence map›Paper›PMID 31462889›Full record

ArticleNordisk alkohol- & narkotikatidskrift : NAT2018

Contribution of alcohol and drug co-use to substance use problems: Data from a nationally-representative sample of U.S. adults who have never been to treatment.

Katherine J Karriker-Jaffe, Meenakshi S Subbaraman, Thomas K Greenfield, William C Kerr

Open access · diamondAbstract read
In one paragraph

Article in Nordisk alkohol- & narkotikatidskrift : NAT, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Comment on Karriker-Jaffe et al.Nordisk alkohol- & narkotikatidskrift : NAT · 2018
    Article
  9. More social research into polydrug use.Nordisk alkohol- & narkotikatidskrift : NAT · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Katherine J Karriker-JaffeAlcohol Research Group, Public Health Institute, Emeryville, CA, USA.
Meenakshi S SubbaramanAlcohol Research Group, Public Health Institute, Emeryville, CA, USA.
Thomas K GreenfieldAlcohol Research Group, Public Health Institute, Emeryville, CA, USA.
William C KerrAlcohol Research Group, Public Health Institute, Emeryville, CA, USA.
Public Health Institute · US

Funding

TREND &STRUCTURE OF ALCOHOL DEPENDENCE--GENERAL POPULATION 1990 SURVEY DATAP50AA005595 · NIAAA · WESTERN CONSORTIUM FOR PUBLIC HEALTH · PI MULIA, NINA · 1985 to 2025
$34.1M
How Cannabis Use Affects Alcohol Treatment OutcomesR21AA023039 · NIAAA · PUBLIC HEALTH INSTITUTE · PI SUBBARAMAN, MEENAKSHI S · 2015 to 2016
$335k
NIAAA NIH HHS P50 AA005595NIAAA NIH HHS R21 AA023039
6 · The paper itself

Abstract

aimsCombined use of alcohol with drugs elevates risk for problems including injury and intoxicated driving. We assessed contributions of heavy drinking (5+ men/4+ women), drug use (cannabis and other drugs) and simultaneous co-use to DSM-5 alcohol use disorder (AUD) and drug abuse (DA). We expected co-use to increase risk for AUD and DA.

methodsUsing population-weighted data from adults in the 2014-15 National Alcohol Survey who had never been to treatment (N=3386 drinkers, 50% male, 13% Hispanic, 11% Black, mean age 45; N=439 drug users, 56% male, 20% Hispanic, 15% Black, mean age 36), we tested hypotheses using logistic regression adjusting for demographics, family history of alcohol problems and impulsivity.

results10% of drinkers and 26% of drug users met criteria for mild AUD; <1% of drinkers and 4% of drug users met criteria for DA. Heavy drinking significantly increased risk for AUD, as did monthly or weekly use of cannabis. When simultaneous co-use was added, increased risk associated with cannabis use was reduced to non-significance. Weekly cannabis use, weekly use of other drugs and simultaneous drug and alcohol co-use were associated with significantly elevated risk of DA. In bivariate analyses, simultaneous co-use was associated with significantly greater endorsement of each of the separate AUD and DA symptom domains, including alcohol craving, tolerance and withdrawal, as well as drug and alcohol social and physical health problems.

conclusionHealthcare providers should screen for simultaneous co-use of alcohol and drugs to help identify patients who may benefit from substance abuse treatment.

Identifiers

PMID31462889
PMCPMC6713484
OpenAlexW2904244728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.